Care365.caYour health is one click away
Menu
Vaccine product guide

CAPVAXIVE

Pneumococcal 21-valent conjugate (Pneu-C-21) · Pneumococcal

Health Canada DIN 02549891. Check the product and formulation on your record before using a schedule.

Plan doses for this product →
DIN
02549891
Family
Pneumococcal
Guidance checked
2026-09-27
← All Pneumococcal products

About this vaccine

Capvaxive is a vaccine that helps protect adults against serious infections caused by a group of pneumococcus bacteria.

CAPVAXIVE is listed under Health Canada DIN 02549891. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.

At a glance

Brand
CAPVAXIVE
DIN
02549891
Vaccine
Pneumococcal 21-valent conjugate (Pneu-C-21)
Presentation
0.5 mL · solution · intramuscular · 18 years and older
Live vaccine
No

Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.

Official sources

Use the DIN to confirm this exact product in Health Canada's Drug Product Database.

Health CanadaMonograph PDF

A listed product may not be stocked or publicly funded.

Before and after your vaccination

  • Bring your immunization record if you have one, so earlier doses can be checked.
  • Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
  • After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
  • Keep a record of the vaccine name, date and dose you received.

These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.

Practical guidance for CAPVAXIVE

The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.

What this vaccine helps prevent

  • Capvaxive is a vaccine that helps protect adults against serious infections caused by a group of pneumococcus bacteria.
  • These infections can include pneumonia, meningitis, and bloodstream infections.
  • It is given as a single shot and is meant for adults, not children.

What to mention before a dose

  • Tell your healthcare professional, doctor, or nurse if you have ever had a serious allergic reaction to a vaccine that contains diphtheria toxoid.
  • Tell them if you have a bleeding problem or take blood thinners.
  • Tell them if your immune system is weakened, whether from a health condition or from medicines you take, since the vaccine may work less well.
  • Tell them if you have a fever or feel quite unwell right now, since your vaccine may need to be delayed.
  • Tell them if you have already received a different pneumococcal vaccine, and if so, roughly when.

How it is given

  • This vaccine is given as a single shot into a muscle, usually in your upper arm, by a doctor, healthcare professional, or nurse.
  • You do not take this at home, and there is nothing for you to swallow or apply yourself.
  • If you have had a different pneumococcal vaccine before, your care team will tell you whether and when you should have this one too.

Important things to know

  • This vaccine cannot protect everyone who gets it, and it only protects against the specific bacteria types it targets, not every cause of pneumonia.
  • Serious allergic reactions are rare but possible with any vaccine, including this one.

Effects you may notice

  • Soreness where you got the shot is very common.
  • Feeling tired is very common.
  • Headache is common.
  • Muscle aches are common.
  • Redness or swelling at the injection site can happen.
  • A mild fever or chills can happen.
  • An upset stomach, including nausea or diarrhea, can happen.
  • Feeling dizzy can happen.
  • Swollen glands can happen.
  • Itching where you got the shot can happen.

When to contact a healthcare professional

  • Contact your healthcare professional if redness or swelling at the injection site gets worse or spreads.
  • Contact your healthcare professional if a fever is high or does not go away.
  • Contact your healthcare professional if you have questions about whether you need this vaccine or have had it before.

When to get emergency help

  • Get emergency help if you have swelling of the face, lips, or throat.
  • Get emergency help for trouble breathing or wheezing.
  • Get emergency help for a widespread rash or hives all over the body.
  • Get emergency help for fainting that does not quickly clear up.

Other medicines and vaccines

  • Food and drink do not affect this vaccine in any way.
  • Tell your healthcare professional or doctor about any other medicines you take, including ones that weaken your immune system, since these can sometimes make the vaccine work less well.
  • This vaccine can be given at the same visit as a flu shot, but in a different arm or injection site.

Key points to remember

  • Bring your immunization record to your appointment so your care team can keep it up to date.
  • Stay at the clinic for a short period after your shot, as advised by your care team, in case of a reaction.
  • Ask your healthcare professional or doctor whether this vaccine is recommended for you based on your age and health conditions.

The practical points are adapted from the Pharmasist reference for CAPVAXIVE and its matching product monograph.

Dose schedules

These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.

Pneumococcal conjugate — adults 65 and older, one dose

1 dose

One dose of Pneu-C-20 or Pneu-C-21 for all adults 65 years and older.

All adults 65 years and older: one dose of Pneu-C-20 or Pneu-C-21 regardless of earlier pneumococcal vaccination, given at least 1 year after any previous Pneu-C-13, Pneu-C-15 or Pneu-P-23 dose (8 weeks in some circumstances). No further doses are currently recommended.

Pneumococcal conjugate — adults 18 to 64 with risk factors, one dose

1 dose

One dose of Pneu-C-20 or Pneu-C-21 for adults 18 to 64 with a condition that raises the risk of pneumococcal disease.

Adults 18 to 64 with immunocompromising conditions (HIV, asplenia, transplant, cancer, immunosuppressive therapy) or other risk factors for invasive pneumococcal disease (chronic heart, lung, kidney or liver disease, diabetes, alcohol use disorder, cochlear implant, CSF leak): one dose at least 8 weeks after any earlier pneumococcal vaccine. Stem-cell transplant recipients need a three-dose series plus booster instead.

Check your dose plan →

Pregnancy and breastfeeding

Family guidance on pregnancy: Recommended for people at high risk of pneumococcal disease.

Family guidance on breastfeeding: Recommended for people at high risk of pneumococcal disease.

This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.

References and product information

General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.

Explore care options